The Pseudomonas Aeruginosa PA01 Gene Collection

Overview

Journal Genome Res

Specialty Genetics

Date 2004 Oct 19

PMID 15489342

Citations 46

Authors

Joshua LaBaer

Qingqing Qiu

Anukanth Anumanthan

Wenhong Mar

Dongmei Zuo

T V S Murthy

Helen Taycher

Allison Halleck

Eugenie Hainsworth

Stephen Lory

Leonardo Brizuela

Affiliations

Soon will be listed here.

Abstract

Pseudomonas aeruginosa, a common inhabitant of soil and water, is an opportunistic pathogen of growing clinical relevance. Its genome, one of the largest among bacteria [5570 open reading frames (ORFs)] approaches that of simple eukaryotes. We have constructed a comprehensive gene collection for this organism utilizing the annotated genome of P. aeruginosa PA01 and a highly automated and laboratory information management system (LIMS)-supported production line. All the individual ORFs have been successfully PCR-amplified and cloned into a recombination-based cloning system. We have isolated and archived four independent isolates of each individual ORF. Full sequence analysis of the first isolate for one-third of the ORFs in the collection has been completed. We used two sets of genes from this repository for high-throughput expression and purification of recombinant proteins in different systems. The purified proteins have been used to set up biochemical and immunological assays directed towards characterization of histidine kinases and identification of bacterial proteins involved in the immune response of cystic fibrosis patients. This gene repository provides a powerful tool for proteome- and genome-scale research of this organism, and the strategies adopted to generate this repository serve as a model for building clone sets for other bacteria.

Citing Articles

Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.

Zhang Y, Bharathi V, Dokoshi T, de Anda J, Ursery L, Kulkarni N Proc Natl Acad Sci U S A. 2024; 121(6):e2300644120.

PMID: 38306481 PMC: 10861912. DOI: 10.1073/pnas.2300644120.

Virulence attenuating combination therapy: a potential multi-target synergy approach to treat infections in cystic fibrosis patients.

Shaw E, Wuest W RSC Med Chem. 2021; 11(3):358-369.

PMID: 33479641 PMC: 7580779. DOI: 10.1039/c9md00566h.

Mobilization of Iron Stored in Bacterioferritin Is Required for Metabolic Homeostasis in .

Punchi Hewage A, Fontenot L, Guidry J, Weldeghiorghis T, Mehta A, Donnarumma F Pathogens. 2020; 9(12).

PMID: 33255203 PMC: 7760384. DOI: 10.3390/pathogens9120980.

Exercise and Cystic Fibrosis.

Ding S, Zhong C Adv Exp Med Biol. 2020; 1228:381-391.

PMID: 32342472 DOI: 10.1007/978-981-15-1792-1_26.

The Pseudomonas aeruginosa PilSR Two-Component System Regulates Both Twitching and Swimming Motilities.

Kilmury S, Burrows L mBio. 2018; 9(4).

PMID: 30042200 PMC: 6058289. DOI: 10.1128/mBio.01310-18.

References

Macfarlane E, Kwasnicka A, Ochs M, Hancock R . PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol Microbiol. 1999; 34(2):305-16. DOI: 10.1046/j.1365-2958.1999.01600.x. View

Tan M, Rahme L, Sternberg J, Tompkins R, Ausubel F . Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci U S A. 1999; 96(5):2408-13. PMC: 26797. DOI: 10.1073/pnas.96.5.2408. View

Stover C, Pham X, Erwin A, Mizoguchi S, Warrener P, Hickey M . Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000; 406(6799):959-64. DOI: 10.1038/35023079. View

Stock A, Robinson V, Goudreau P . Two-component signal transduction. Annu Rev Biochem. 2000; 69:183-215. DOI: 10.1146/annurev.biochem.69.1.183. View

Rodrigue A, Quentin Y, Lazdunski A, Mejean V, Foglino M . Two-component systems in Pseudomonas aeruginosa: why so many?. Trends Microbiol. 2000; 8(11):498-504. DOI: 10.1016/s0966-842x(00)01833-3. View

Moss J, Ehrmantraut M, Banwart B, Frank D, Barbieri J . Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus. Infect Immun. 2001; 69(2):1185-8. PMC: 98003. DOI: 10.1128/IAI.69.2.1185-1188.2001. View

Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P . Global analysis of protein activities using proteome chips. Science. 2001; 293(5537):2101-5. DOI: 10.1126/science.1062191. View

Brizuela L, Braun P, LaBaer J . FLEXGene repository: from sequenced genomes to gene repositories for high-throughput functional biology and proteomics. Mol Biochem Parasitol. 2001; 118(2):155-65. DOI: 10.1016/s0166-6851(01)00366-8. View

Gavin A, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A . Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 2002; 415(6868):141-7. DOI: 10.1038/415141a. View

10.

Banwart B, Splaingard M, Farrell P, Rock M, Havens P, Moss J . Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. J Infect Dis. 2002; 185(2):269-70. DOI: 10.1086/338197. View

11.

Braun P, Hu Y, Shen B, Halleck A, Koundinya M, Harlow E . Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci U S A. 2002; 99(5):2654-9. PMC: 122403. DOI: 10.1073/pnas.042684199. View

12.

Drenkard E, Ausubel F . Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature. 2002; 416(6882):740-3. DOI: 10.1038/416740a. View

13.

Masignani V, Rappuoli R, Pizza M . Reverse vaccinology: a genome-based approach for vaccine development. Expert Opin Biol Ther. 2003; 2(8):895-905. DOI: 10.1517/14712598.2.8.895. View

14.

Ratjen F, Doring G . Cystic fibrosis. Lancet. 2003; 361(9358):681-9. DOI: 10.1016/S0140-6736(03)12567-6. View

15.

Phizicky E, Bastiaens P, Zhu H, Snyder M, Fields S . Protein analysis on a proteomic scale. Nature. 2003; 422(6928):208-15. DOI: 10.1038/nature01512. View

16.

Reboul J, Vaglio P, Rual J, Lamesch P, Martinez M, Armstrong C . C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat Genet. 2003; 34(1):35-41. DOI: 10.1038/ng1140. View

17.

McKevitt M, Patel K, Smajs D, Marsh M, McLoughlin M, Norris S . Systematic cloning of Treponema pallidum open reading frames for protein expression and antigen discovery. Genome Res. 2003; 13(7):1665-74. PMC: 403740. DOI: 10.1101/gr.288103. View

18.

Wolfgang M, Kulasekara B, Liang X, Boyd D, Wu K, Yang Q . Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2003; 100(14):8484-9. PMC: 166255. DOI: 10.1073/pnas.0832438100. View

19.

McPhee J, Lewenza S, Hancock R . Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol. 2003; 50(1):205-17. DOI: 10.1046/j.1365-2958.2003.03673.x. View

20.

Potvin E, Lehoux D, Kukavica-Ibrulj I, Richard K, Sanschagrin F, Lau G . In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol. 2003; 5(12):1294-308. DOI: 10.1046/j.1462-2920.2003.00542.x. View